Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 13 of 30.
Jun 2021
May 2021
26 May · Board meeting
Apr 2021
19 Apr · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
16 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
14 Apr · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....
Shareholding for the Period Ended March 31, 202112 Apr · Confirmation Regarding Non Applicability Of SEBI Circular Dated 26 November, 2018
12 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For Half Year Ended 31 March, 2021
12 Apr · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 0 1
Statement Of Investor Complaints For The Quarter Ended March 2021
Feb 2021
11 Feb · Results
11 Feb · Board meeting
Jan 2021
18 Jan · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....
Shareholding for the Period Ended December 31, 20208 Jan · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended December 2020
Dec 2020
15 Dec · Updates
15 Dec · Updation Of Contact Details Of Registrar & Transfer Agent
4 Dec · Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 ("SEBI LODR") - Details Of Related Party Transactions
Nov 2020
6 Nov · Board meeting
6 Nov · Results
6 Nov · Board meeting
Oct 2020
27 Oct · Board meeting
20 Oct · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
15 Oct · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
Shareholding for the Period Ended September 30, 202014 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosurerequirements)Regulations, 2015.
14 Oct · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2 0 2 0
Statement Of Investor Complaints For The Quarter Ended September 202014 Oct · Updates
Sep 2020
26 Sep · Results
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)25 Sep · Meeting
25 Sep · Meeting